MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1038/s41467-022-33767-y

Медицинская библиотека · Nature communications · 2022

Fibroblast A20 governs fibrosis susceptibility and its repression by DREAM promotes fibrosis in multiple organs.

Wang Wenxia, Bale Swarna, Wei Jun, Yalavarthi Bharath, Bhattacharyya Dibyendu, Yan Jing Jing, Abdala-Valencia Hiam, Xu Dan, Sun Hanshi, Marangoni Roberta G, Herzog Erica, Berdnikovs Sergejs, Miller Stephen D, Sawalha Amr H, Tsou Pei-Suen, Awaji Kentaro, Yamashita Takashi, Sato Shinichi, Asano Yoshihide, Tiruppathi Chinnaswamy, Yeldandi Anjana, Schock Bettina C, Bhattacharyya Swati, Varga John

СтатьяПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

In addition to autoimmune and inflammatory diseases, variants of the TNFAIP3 gene encoding the ubiquitin-editing enzyme A20 are also associated with fibrosis in systemic sclerosis (SSc). However, it remains unclear how genetic factors contribute to SSc pathogenesis, and which cell types drive the disease due to SSc-specific genetic alterations. We therefore characterize the expression, function, and role of A20, and its negative transcriptional regulator DREAM, in patients with SSc and disease models. Levels of A20 are significantly reduced in SSc skin and lungs, while DREAM is elevated. In isolated fibroblasts, A20 mitigates ex vivo profibrotic responses. Mice haploinsufficient for A20, or harboring fibroblasts-specific A20 deletion, recapitulate major pathological features of SSc, whereas DREAM-null mice with elevated A20 expression are protected. In DREAM-null fibroblasts, TGF-β induces the expression of A20, compared to wild-type fibroblasts. An anti-fibrotic small molecule targeting cellular adiponectin receptors stimulates A20 expression in vitro in wild-type but not A20-deficient fibroblasts and in bleomycin-treated mice. Thus, A20 has a novel cell-intrinsic function in restraining fibroblast activation, and together with DREAM, constitutes a critical regulatory network governing the fibrotic process in SSc. A20 and DREAM represent novel druggable targets for fibrosis therapy.

Для цитирования: Wang Wenxia, Bale Swarna, Wei Jun, Yalavarthi Bharath, Bhattacharyya Dibyendu, Yan Jing Jing, Abdala-Valencia Hiam, Xu Dan, Sun Hanshi, Marangoni Roberta G, Herzog Erica, Berdnikovs Sergejs, Miller Stephen D, Sawalha Amr H, Tsou Pei-Suen, Awaji Kentaro, Yamashita Takashi, Sato Shinichi, Asano Yoshihide, Tiruppathi Chinnaswamy, Yeldandi Anjana, Schock Bettina C, Bhattacharyya Swati, Varga John. Fibroblast A20 governs fibrosis susceptibility and its repression by DREAM promotes fibrosis in multiple organs.. Nature communications. 2022. DOI: 10.1038/s41467-022-33767-y.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.